Alzheimer's Disease Research GrantsFUNDING PERIOD: APRIL 1, 2005 – MARCH 31, 2006 Gary E. Landreth, Ph.D.
FUNDING PERIOD: APRIL 1, 2005 – MARCH 31, 2006 Gary Landreth, Ph.D. There is good evidence that neurons in the AD brain have experienced oxidative damage, impairing the function of neuronal proteins, lipids and DNA. The microglial enzyme that produces free oxygen radicals is termed NADPH oxidase, and has to be assembled from several subunits to be active. Amyloid fibrils have been found to stimulate assembly of this oxidase. One goal of Dr. Landreth’s study is to understand how the binding of amyloid fibrils to the cell results in assembly and activation of the NADPH oxidase. His studies will determine if knocking out the oxidase results in lower levels of oxidative damage in an AD mouse model. These studies are of therapeutic importance as anti-oxidants are currently being considered for the treatment of AD.
|